跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Linsul - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Linsul
Approved
STANDARD
Linsul
Samjin Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f3ab5ace109b9a9d
Company
Samjin Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
f3ab5ace109b9a9d
Drug Approval Philippines Name
Linsul
Product Name
Linsul
Registration Number
DRP-3252
Brand Name
Linsul
Generic Name
Ampicillin (as sodium) + Sulbactam (as sodium)
Dosage Form
Powder for Injection (I.M./I.V.)
Dosage Strength
500mg/250mg
Manufacturer
Samjin Pharmaceutical Co., Ltd.
Importer
Medbridge Inc.
Distributor
Medbridge Inc.
Company Detail Path
/organization/samjin-pharmaceutical-co-ltd
Issuance Date
29 March 2021
Expiry Date
03 March 2026
Pharmacologic Category
Antibacterial(Penicillin-Beta-Lactamase Inhibitor Combination)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f3ab5ace109b9a9d
Type
Standard
Back to Philippines FDA Approvals